Cargando…

ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer

Detalles Bibliográficos
Autores principales: Mangsbo, Sara M, Broos, Sissela, Gustafsson, Erika, Furebring, Christina, Veitonmäki, Niina, Dahlen, Eva, Norlen, Per, Lindstedt, Malin, Tötterman, Thomas, Ellmark, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991342/
http://dx.doi.org/10.1186/2051-1426-1-S1-P42
_version_ 1782312418800566272
author Mangsbo, Sara M
Broos, Sissela
Gustafsson, Erika
Furebring, Christina
Veitonmäki, Niina
Dahlen, Eva
Norlen, Per
Lindstedt, Malin
Tötterman, Thomas
Ellmark, Peter
author_facet Mangsbo, Sara M
Broos, Sissela
Gustafsson, Erika
Furebring, Christina
Veitonmäki, Niina
Dahlen, Eva
Norlen, Per
Lindstedt, Malin
Tötterman, Thomas
Ellmark, Peter
author_sort Mangsbo, Sara M
collection PubMed
description
format Online
Article
Text
id pubmed-3991342
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39913422014-05-05 ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer Mangsbo, Sara M Broos, Sissela Gustafsson, Erika Furebring, Christina Veitonmäki, Niina Dahlen, Eva Norlen, Per Lindstedt, Malin Tötterman, Thomas Ellmark, Peter J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991342/ http://dx.doi.org/10.1186/2051-1426-1-S1-P42 Text en Copyright © 2013 Mangsbo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Mangsbo, Sara M
Broos, Sissela
Gustafsson, Erika
Furebring, Christina
Veitonmäki, Niina
Dahlen, Eva
Norlen, Per
Lindstedt, Malin
Tötterman, Thomas
Ellmark, Peter
ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
title ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
title_full ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
title_fullStr ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
title_full_unstemmed ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
title_short ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
title_sort adc-1013, an agonistic cd40 antibody optimized for local immunotherapy of cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991342/
http://dx.doi.org/10.1186/2051-1426-1-S1-P42
work_keys_str_mv AT mangsbosaram adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT broossissela adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT gustafssonerika adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT furebringchristina adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT veitonmakiniina adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT dahleneva adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT norlenper adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT lindstedtmalin adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT tottermanthomas adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer
AT ellmarkpeter adc1013anagonisticcd40antibodyoptimizedforlocalimmunotherapyofcancer